资源 » 参考数据库 » 客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

miR-26a induced the suppression of tumor growth of cholangiocarcinoma via KRT19 approach.

Oncotarget. 2016;

WangPing，Lv

Products/Services Used	Details	Operation
Custom Vector Construction	The 3′-UTR sequence of KRT19 predicted to interact with miR-26a or a mutated sequence with the predicted target sites were inserted into pGL3 promoter vector (Genscript, Nanjing, China).	Get A Quote

摘要

KRT19 was identified as one of the key biomarkers for distinguishing cholangiocarcinoma (CCA) and hepatocellular carcinoma. The detailed role of miRNAs involved in the oncogenic incident of KRT19 was poor investigated.